Unknown

Dataset Information

0

Molecular Testing for Mycoplasma genitalium in the United States: Results from the AMES Prospective Multicenter Clinical Study.


ABSTRACT: A prospective multicenter clinical study involving subjects from 21 sites across the United States was conducted to validate the performance of a new in vitro diagnostic nucleic acid amplification test (NAAT) for the detection of Mycoplasma genitalium Seven urogenital specimen types (n?=?11,556) obtained from 1,778 females, aged 15 to 74?years, and 1,583 males, aged 16 to 82?years, were tested with the Aptima Mycoplasma genitalium assay, an investigational transcription-mediated amplification (TMA) NAAT for the detection of M. genitalium 16S rRNA. Infected status for enrolled subjects was established using results obtained from testing either self-collected vaginal swab or clinician-collected male urethral swab specimens with a composite reference method consisting of three transcription-mediated amplification NAATs targeting unique regions of M. genitalium 16S or 23S rRNA. M. genitalium prevalence was 10.2% in females and 10.6% in males; prevalence was high in both symptomatic and asymptomatic subjects for both sexes. Compared to the subject infected status standard, the investigational test had sensitivity and specificity estimates, respectively, of 98.9% and 98.5% for subject-collected vaginal swabs, 92.0% and 98.0% for clinician-collected vaginal swabs, 81.5% and 98.3% for endocervical swabs, 77.8% and 99.0% for female urine, and 98.2% and 99.6% for male urethral swabs, 88.4% and 97.8% for self-collected penile meatal swabs, and 90.9% and 99.4% for male urine specimens. For all seven specimen types, within-specimen positive and negative agreements between the investigational test and the composite reference standard ranged from 94.2% to 98.3% and from 98.5 to 99.9%, respectively. These results provide clinical efficacy evidence for the first FDA-cleared NAAT for M. genitalium detection in the United States.

SUBMITTER: Gaydos CA 

PROVIDER: S-EPMC6813011 | biostudies-literature | 2019 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Molecular Testing for Mycoplasma genitalium in the United States: Results from the AMES Prospective Multicenter Clinical Study.

Gaydos Charlotte A CA   Manhart Lisa E LE   Taylor Stephanie N SN   Lillis Rebecca A RA   Hook Edward W EW   Klausner Jeffrey D JD   Remillard Carmelle V CV   Love Melissa M   McKinney Byron B   Getman Damon K DK  

Journal of clinical microbiology 20191023 11


A prospective multicenter clinical study involving subjects from 21 sites across the United States was conducted to validate the performance of a new <i>in vitro</i> diagnostic nucleic acid amplification test (NAAT) for the detection of <i>Mycoplasma genitalium</i> Seven urogenital specimen types (<i>n</i> = 11,556) obtained from 1,778 females, aged 15 to 74 years, and 1,583 males, aged 16 to 82 years, were tested with the Aptima <i>Mycoplasma genitalium</i> assay, an investigational transcripti  ...[more]

Similar Datasets

2010-11-15 | GSE22661 | GEO
| S-EPMC6802821 | biostudies-literature
| PRJNA13941 | ENA
| PRJNA128005 | ENA
| S-EPMC1947986 | biostudies-literature
| S-EPMC7512161 | biostudies-literature
| S-EPMC7802946 | biostudies-literature
| S-EPMC5554300 | biostudies-other
2010-11-15 | E-GEOD-22661 | biostudies-arrayexpress
| S-EPMC3213402 | biostudies-literature